BioSpace News Archive

Samsung unveils a new ultrasound system ‘HERA W10' powered by beamforming technology at ISUOG World Congress 2018

New image reconstruction architecture designed to support easier diagnosis to enhance workflow and user experience with innovative features and ergonomics

October 21, 2018
·
4 min read
Drug Development

Genentech’s Investigational Personalized Medicine Entrectinib Shrank Tumors in People with NTRK Fusion-Positive Solid Tumors

Entrectinib showed response irrespective of tumor type or spread to the central nervous system (CNS)

October 21, 2018
·
6 min read
Biotech Beach

Mirati Therapeutics Announces Updated Data From Ongoing Clinical Trial Of Single Agent Sitravatinib At The 2018 ESMO Congress

Clinical data in non-small cell lung cancer (NSCLC) and melanoma patients with CBL inactivating mutations treated with single agent sitravatinib demonstrate encouraging results

October 21, 2018
·
5 min read
Drug Development

Taiho Oncology and Servier Announce Positive Results from LONSURF® (trifluridine/tipiracil) Study Presented at ESMO 2018 Congress and Published in The Lancet Oncology

Results from TAGS Trial Meets Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival in Patients with Metastatic Gastric/Gastroesophageal Junction (GEJ) Adenocarcinoma

October 21, 2018
·
12 min read
Drug Development

Larotrectinib Delivers 81% Overall Response Rate in an Expanded Dataset of 109 TRK Fusion Cancer Patients Across Ages and Tumor Types

Median duration of response (mDOR) in primary dataset not reached after follow-up of 17.6 months(1)

October 21, 2018
·
9 min read
Business

2018 Omololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy Celebrates a “Real Powerhouse” Young PrEP Advocate

Gcobisa Madlolo, an activist, a writer, a proud mother of twins and a fresh, inspiring and powerful voice for young women in her native South Africa and beyond is the recipient of the fifth Omololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy.

October 21, 2018
·
4 min read
Drug Development

Leap Therapeutics Presents Esophagogastric Cancer Data at ESMO 2018 Annual Congress

Live conference call and webcast on Monday, October 22 at 8:00 AM ET

October 21, 2018
·
6 min read
Drug Development

Daiichi Sankyo Presents Updated Results of [Fam-] Trastuzumab Deruxtecan (DS-8201) in Patients with HER2 Expressing Advanced Colorectal Cancer at 2018 European Society for Medical Oncology (ESMO) Congress

Updated analysis from ongoing phase 1 study of [fam-] trastuzumab deruxtecan (DS-8201) demonstrated a confirmed overall response rate of 15.8 percent and a disease control rate of 84.2 percent in 19 evaluable patients with heavily pretreated colorectal cancer with varying levels of HER2 expression

October 21, 2018
·
9 min read
Drug Development

Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma

Updated results presented at ESMO support planned submission of NDA in U.S. in 2019

October 21, 2018
·
8 min read
Drug Development

Ipsen Presents Real-World Pancreatic Cancer Data on ONIVYDE® at the European Society for Medical Oncology (ESMO) 2018 Annual Congress

Patients in a real-world setting experienced similar dosing patterns as seen in the pivotal Phase 3 NAPOLI-1 clinical trial

October 21, 2018
·
9 min read